Biography

Epidemiologist Erin Bowles, MPH, is looking at breast cancer screening and treatment from many different perspectives. Her research brings new insight into cancer risk factors, diagnosis, treatment, and survivorship, while helping improve cancer care for patients and families.

Erin received an R50 mid-career research award from the National Cancer Institute (NCI). This award is given to cancer researchers who have demonstrated successes and contributions to cancer research as a non-principal investigator. As a key member of 2 large cancer collaborations — the NCI's Breast Cancer Surveillance Consortium and the Kaiser Permanente Breast Cancer Survivors Cohort — Erin has developed diverse expertise that includes reading mammograms for breast density and using administrative data to understand patterns of breast cancer screening and cancer treatment.

Her current work includes:

• Collaborating on a multi-site study with investigators from Memorial Sloan Kettering Cancer Center, Kaiser Permanente Northern California, and Rutgers University to understand how obesity affects chemotherapy treatment dosing and risks of recurrence and toxicity in women with breast cancer
• Helping investigators from Kaiser Permanente Northern California and the University of California (UC) San Francisco and UC Davis understand imaging trends in children and pregnant women, and subsequent risks of leukemia associated with ionizing radiation from imaging exams
• Working with investigators from the NCI, Kaiser Permanente Colorado, Kaiser Permanente Georgia, and Kaiser Permanente Hawaii to study how mammographic breast density, radiation treatment, and tissue biomarkers are associated with second cancers in women with previous breast cancer
• Collaborating on several studies within the BCSC to understand how disparities, access to advanced technology like artificial intelligence, and social drivers of health affect breast cancer screening, diagnosis, and surveillance
• Working with teams from the Centers for Disease Control and Prevention, University of Washington, Henry Ford Health System, and Multicare Health System to develop and validate questions about cancer screening for people eligible for breast, colorectal, cervical, and/or lung cancer screening for the National Health Interview Survey.

Erin’s experience working with large observational cohorts and collaborations with numerous study teams over the past 20+ years has provided her with expertise in data collection and quality control for many subject areas. She is also Director of the Collaborative Science Division at KPWHRI, providing leadership, supervision, mentorship, and support to collaborative scientists with a range of skills and expertise. She is passionate about providing long-term career paths for masters- and PhD-level scientists who don’t want to become independent investigators.